Coverage
-
October 14, 2020
A New York federal judge tossed a proposed class action Wednesday that alleged pharmaceutical research and development company WuXi PharmaTech misled investors by not disclosing a strategy to spin off three subsidiaries.
2 other articles on this case.
View all »